Select for export From Venerable Cultural Practices to Modern Psychological Solutions: Enter Entheogens into Mainstream Medicine Abstract available at the source but not redistributed here. Read at source. Details DOI 10.59324/ejahss.2024.1(3).10 Copy citation Copy BibTeX European Journal of Arts Humanities and Social Sciences 2024-04-30 Nicholas A Kerna, Kevin D. Pruitt, N.D. Victor Carsrud, Kyle Kadivi, Dabeluchi C. Ngwu, Hilary M. Holets OpenAlex Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export In the new era of psychedelic assisted therapy: A systematic review of study methodology in randomized controlled trials. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-024-06598-6 PubMed 38683460 Copy citation Copy BibTeX Unknown journal 2024-04-28 Soliman PS, Curley DE, Capone C, Eaton E, Haass-Koffler CL. Europe PMC Published psilocybin Randomized Controlled TrialSystematic ReviewReview Article Randomized Controlled Trial More
Select for export Review of Psilocybin Use for Depression among Cancer Patients after Approval in Oregon Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3390/cancers16091702 PubMed 38730654 Copy citation Copy BibTeX Cancers 2024-04-26 Val Bellman OpenAlex Published psilocybin DepressionEnd-of-Life DistressReview Article Review Article More
Select for export The ‘PSILAUT’ protocol: an experimental medicine study of autistic differences in the function of brain serotonin targets of psilocybin Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1186/s12888-024-05768-2 PubMed 38658877 Copy citation Copy BibTeX BMC Psychiatry 2024-04-24 Tobias P. Whelan, Eileen Daly, Nicolaas A.J. Puts, Paula Smith, Carrie Allison, Simon Baron-Cohen OpenAlex Published psilocybin Chronic PainBrain ImagingMechanism of Action Clinical Trial More
Select for export Visual hallucinations originating in the retinofugal pathway under clinical and psychedelic conditions. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.euroneuro.2024.04.011 PubMed 38648694 Copy citation Copy BibTeX Unknown journal 2024-04-20 Tipado Z, Kuypers KPC, Sorger B, Ramaekers JG. Europe PMC Published psilocybin Mechanism of ActionReceptor Pharmacology Other More
Select for export Palliative care patients’ attitudes and openness towards psilocybin-assisted psychotherapy for existential distress Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2024.1301960 PubMed 38699449 Copy citation Copy BibTeX Frontiers in Psychiatry 2024-04-17 Julia R. Wang, Samuel J. Mendez Araque, Gina Micciche, Andrew McMillan, Emily Coughlin, Rosalie Mattiola OpenAlex Published psilocybin AnxietyEnd-of-Life DistressChronic Pain Observational Study More
Select for export Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/14728214.2024.2342951 PubMed 38606899 Copy citation Copy BibTeX Unknown journal 2024-04-17 Köhne S, Hillemacher T, Glahn A, Bach P. Europe PMC Published psilocybin AddictionClinical TrialReview Article Clinical Trial More
Select for export Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41598-024-58318-x PubMed 38632313 Copy citation Copy BibTeX Scientific Reports 2024-04-16 Jordan Sloshower, Richard J. Zeifman, Jeffrey Guss, Robert Krause, Hamideh Safi-Aghdam, Surbhi Pathania OpenAlex Published psilocybin DepressionAnxietyMechanism of Action Clinical Trial More
Select for export Mind the Psychedelic Hype: Characterizing the Risks and Benefits of Psychedelics for Depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3390/psychoactives3020014 Copy citation Copy BibTeX Psychoactives 2024-04-15 Daniel Meling, Rebecca Ehrenkranz, Sandeep M. Nayak, Helena Aicher, Xaver Funk, Michiel van Elk OpenAlex Published psilocybin DepressionReceptor PharmacologyReview Article Review Article More
Select for export Psychedelic therapists, pharma collaborate on clinical trial Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/mhw.34009 Copy citation Copy BibTeX Mental Health Weekly 2024-04-12 Valerie A. Canady OpenAlex Published psilocybin Clinical TrialRandomized Controlled Trial Randomized Controlled Trial More
Select for export Who will staff the psychedelic resurgence? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.56367/oag-042-10690 Copy citation Copy BibTeX Open Access Government 2024-04-08 Erika Dyck OpenAlex Published psilocybin DepressionAddictionClinical Trial Clinical Trial More
Select for export Mechanisms of therapeutic change after psychedelic treatment in OCD No abstract availability was recorded for this entry. Details DOI 10.1016/j.psychres.2024.115907 PubMed 38615521 Copy citation Copy BibTeX Psychiatry Research 2024-04-06 Gayle Maloney, Terence H. W. Ching, Stephen A. Kichuk, Christopher Pittenger, Benjamin Kelmendi OpenAlex Published psilocybin OCDMechanism of ActionReceptor Pharmacology Qualitative Study More
Select for export Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.pharmthera.2024.108641 PubMed 38583670 Copy citation Copy BibTeX Unknown journal 2024-04-05 Haniff ZR, Bocharova M, Mantingh T, Rucker JJ, Velayudhan L, Taylor DM Europe PMC Published psilocybin DepressionNeuroplasticityNeurogenesis Clinical Trial More
Select for export A double-edged sword: Insights from practitioners on the short and long-term negative effects of psilocybin-assisted psychological interventions Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1556/2054.2024.00337 Copy citation Copy BibTeX Journal of Psychedelic Studies 2024-04-01 M. Nordin, Jón Ingi Hlynsson, Jakob Håkansson Eklund, Per Carlbring OpenAlex Published psilocybin Safety Other More
Select for export Microdosing psychedelics in the treatment of ADHD and comorbid disorders Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1192/j.eurpsy.2024.44 Copy citation Copy BibTeX European Psychiatry 2024-03-31 Kim P. C. Kuypers OpenAlex Published psilocybin DepressionChronic PainNeuroplasticity Clinical Trial More
Select for export The Promise of Therapeutic Psilocybin: An Evaluation of the 134 Clinical Trials, 54 Potential Indications, and 0 Marketing Approvals on ClinicalTrials.gov Abstract available at the source but not redistributed here. Read at source. Details DOI 10.2147/dddt.s443177 PubMed 38618282 Copy citation Copy BibTeX Drug Design Development and Therapy 2024-03-31 Sarah A. Norring, Michael G. Spigarelli OpenAlex Published psilocybin PharmacologyClinical TrialObservational Study Clinical Trial More
Select for export Psychedelic Renaissance: Evidence and Culture Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2024.04.4.39 Copy citation Copy BibTeX Psychiatric News 2024-03-20 Adrian Preda OpenAlex Published psilocybin DepressionPTSDNeuroplasticity Clinical Trial More
Select for export Psychedelic drugs and the law: What’s next? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1146/knowable-031424-2 Copy citation Copy BibTeX Knowable Magazine 2024-03-13 Ben Seal OpenAlex Published psilocybinpsilocin DepressionAnxietyPTSD Systematic Review More
Select for export The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1371/journal.pone.0300501 PubMed 38483940 Copy citation Copy BibTeX PLoS ONE 2024-03-13 Adam W. Levin, Rafael Lancelotta, Nathan D. Sepeda, Natalie Gukasyan, Sandeep M. Nayak, Theodore L. Wagener OpenAlex Published psilocybin DepressionMystical ExperienceClinical Trial Randomized Controlled Trial More
Select for export Psychedelic Therapy: A Primer for Primary Care Clinicians-Historical Perspective and Overview Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/mjt.0000000000001727 PubMed 38518266 Copy citation Copy BibTeX American Journal of Therapeutics 2024-02-29 Burton J. Tabaac, Kenneth Shinozuka, Alejandro Arenas, Bryce D. Beutler, Kirsten Cherian, Viviana D. Evans OpenAlex Published psilocybin DepressionAnxietyPTSD Randomized Controlled Trial More
